Partnering / Partnering with HRA
HRA Pharma maximizes the value of its portfolio via in- and out- licensing agreements. The company currently markets both proprietary and in–licensed products in France and parts of Europe, and out-licenses its products to marketing partners in other areas.
Reproductive health and endocrinology are our target sectors in which we project to grow both organically and through targeted acquisitions of products or projects that will strengthen and complement our product portfolio. HRA Pharma is also open to pursuing new opportunities outside of these sectors that will enhance our capabilities, augment our therapeutic offerings and fill unsatisfied therapeutic gaps.
By providing strong and accurate medical, regulatory, sales and marketing expertise, HRA Pharma is committed to developing new in-licensing and collaborative development opportunities.
We look forward to the opportunity to work with you.